RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NanoViricides - Stock

NanoViricides P/E 2024

NanoViricides P/E

-3.43

Ticker

NNVC

ISIN

US6300873022

WKN

A2PSNF

As of Jun 27, 2024, NanoViricides's P/E ratio was -3.43, a 93.79% change from the -1.77 P/E ratio recorded in the previous year.

The NanoViricides P/E history

NanoViricides Aktienanalyse

What does NanoViricides do?

NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. The company's unique technology is based on nanoparticles that specifically target and destroy virus cells. The company was founded in 2005 by Farooq Ansari, a former top manager at Pfizer. Together with his team, he quickly recognized the potential of nanotechnology in combating diseases and began developing various products based on this technology. NanoViricides Inc.'s business model is based on the development and commercialization of nanoparticle-based therapeutics in the global health market. The company works closely with leading research and development institutions to expand knowledge and technology in this field. NanoViricides Inc. has several product divisions specializing in combating different virus infections. The main divisions are: - FluCide: Focuses on the development of therapeutics for the treatment of influenza infections. Flu is one of the most widespread virus infections worldwide and can lead to serious complications such as pneumonia. - HerpeCide: Focuses on the development of therapeutics for the treatment of herpesvirus infections, including genital herpes, shingles, and chickenpox. - HIVCide: Focuses on the development of therapeutics for the treatment of HIV infections, aiming to develop a safer and more effective cure for HIV. - RabiCide: Focuses on the development of therapeutics for the treatment of rabies infections. - CoronaCide: Focuses on the development of therapeutics for the treatment of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. NanoViricides Inc. has a range of products in various stages of development and research, with some already in clinical studies. The company continuously strives to improve its products and expand its research and development efforts. In summary, NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. It utilizes a unique technology based on nanoparticles to directly combat viruses at the cellular level. With multiple product divisions and a strong team of researchers and developers, NanoViricides Inc. is continuously working to improve the health of patients worldwide. The answer is: NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for virus infections using nanoparticle-based technology. NanoViricides ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering NanoViricides's P/E Ratio

The Price to Earnings (P/E) Ratio of NanoViricides is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing NanoViricides's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of NanoViricides is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in NanoViricides’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about NanoViricides Stock

What is the price-to-earnings ratio of NanoViricides?

The price-earnings ratio of NanoViricides is currently -3.43.

How has the price-earnings ratio of NanoViricides changed compared to last year?

The price-to-earnings ratio of NanoViricides has increased by 93.79% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of NanoViricides high compared to other companies?

Yes, the price-to-earnings ratio of NanoViricides is high compared to other companies.

How does an increase in the price-earnings ratio of NanoViricides affect the company?

An increase in the price-earnings ratio of NanoViricides would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of NanoViricides affect the company?

A decrease in the price-earnings ratio of NanoViricides would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of NanoViricides?

Some factors that influence the price-earnings ratio of NanoViricides are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does NanoViricides pay?

Over the past 12 months, NanoViricides paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NanoViricides is expected to pay a dividend of 0 USD.

What is the dividend yield of NanoViricides?

The current dividend yield of NanoViricides is .

When does NanoViricides pay dividends?

NanoViricides pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NanoViricides?

NanoViricides paid dividends every year for the past 0 years.

What is the dividend of NanoViricides?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NanoViricides located?

NanoViricides is assigned to the 'Health' sector.

Wann musste ich die Aktien von NanoViricides kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NanoViricides from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did NanoViricides pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of NanoViricides in the year 2023?

In the year 2023, NanoViricides distributed 0 USD as dividends.

In which currency does NanoViricides pay out the dividend?

The dividends of NanoViricides are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NanoViricides

Our stock analysis for NanoViricides Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoViricides Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.